Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC…
FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
LONDON and NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO),…
LONDON and NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO),…
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients…
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients…
Data will showcase anti-inflammatory and immunomodulatory effects of ASH41020, a novel CSFR1 tyrosine kinase inhibitor…
Data will showcase anti-inflammatory and immunomodulatory effects of ASH41020, a novel CSFR1 tyrosine kinase inhibitor…
COPENHAGEN, Denmark, Aug. 15, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
COPENHAGEN, Denmark, Aug. 15, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
Investigational New Drug (IND) clearance transitions Qualigen from preclinical to clinical-stage company Company divests FastPack®…
Investigational New Drug (IND) clearance transitions Qualigen from preclinical to clinical-stage company Company divests FastPack®…
– AB126 is an unmodified exosome derived from neural stem cells with the innate ability…
– AB126 is an unmodified exosome derived from neural stem cells with the innate ability…
NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
-Clinical outcomes presented at Military Health System Research Symposium (MHSRS)- -Results will be included in…
-Clinical outcomes presented at Military Health System Research Symposium (MHSRS)- -Results will be included in…
NEW YORK and LONDON, Aug. 15, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…